Efficient Method for Generating Point Mutations in the Vaccinia Virus Genome Using CRISPR/Cas9
The vaccinia virus (VACV) was previously used as a vaccine for smallpox eradication. Nowadays, recombinant VACVs are developed as vaccine platforms for infectious disease prevention and cancer treatment. The conventional method for genome editing of the VACV is based on homologous recombination, whi...
Main Authors: | Laetitia Boutin, Estelle Mosca, Frédéric Iseni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/7/1559 |
Similar Items
-
CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses
by: Ming Yuan, et al.
Published: (2016-03-01) -
Fundamental CRISPR-Cas9 tools and current applications in microbial systems
by: Pingfang Tian, et al.
Published: (2017-09-01) -
CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination
by: Tahmina Tabassum, et al.
Published: (2023-09-01) -
A Universal System of CRISPR/Cas9-Mediated Gene Targeting Using All-in-One Vector in Plants
by: Ayako Nishizawa-Yokoi, et al.
Published: (2020-11-01) -
Compact SchCas9 Recognizes the Simple NNGR PAM
by: Shuai Wang, et al.
Published: (2022-02-01)